XTRA:AFXMedical Equipment
Carl Zeiss Meditec (XTRA:AFX) Margin Compression Challenges Bullish Growth Narratives
Carl Zeiss Meditec (XTRA:AFX) Q1 2026 Results in Focus
Carl Zeiss Meditec (XTRA:AFX) has opened its 2026 financial year with Q1 results that put revenue and EPS front and center, with the latest reported quarter showing €627.5 million in revenue and basic EPS of €0.59, alongside net income of €51.8 million. The company has seen revenue move from €579.6 million and basic EPS of €0.70 in Q4 2024 to €627.5 million and €0.59 in Q4 2025, while trailing 12 month basic EPS sat at €1.61 on €2.23...